Louvain-la-Neuve, Belgium

Albemarle Europe Sprl

Calculating rank
USPTO Granted Patents = 8



Forward Citations = 23

Loading Chart...
Loading Chart...

21 inventors (with patents filed for the assignee):

goldMedal Marcel Adriaan Jansen (3 out of 9 patents)

silverMedal Sona Eijsbouts-Spickova (3 out of 11 patents)

bronzeMedal Edgar Evert Steenwinkel (3 out of 3 patents)

4.  Emanuel Hermanus Van Broekhoven (2 out of 12 patents)

5.  Maria Margaret Ludvig (2 out of 3 patents)

6.  Erja Paivi Helena Rautiainen (2 out of 2 patents)

7.  Albert Carel Pouwels (2 out of 2 patents)

8.  Frans Lodewijk Plantenga (2 out of 20 patents)

9.  Bob Gerardus Oogjen (1 out of 11 patents)

10.  Ruben Theodoor Pronk (1 out of 2 patents)

11.  Ralph Klomp (1 out of 1 patent)

12.  Leendert Arie Gerritsen (1 out of 3 patents)

13.  Martijn J M Mies (1 out of 1 patent)

14.  Stephan Janbroers (1 out of 3 patents)

15.  Harmannus Willem Homan Free (1 out of 4 patents)


8 patents:

Company Overview
Albemarle Europe Sprl is a leading global specialty chemicals company, providing innovative solutions to customers in the pharmaceutical, agriculture, energy, and industrial markets. With a focus on sustainability and diversity, Albemarle is committed to creating value for stakeholders while positively impacting communities and the environment.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

8 Patents

#5 in Louvain-la-Neuve

#308 in Belgium

Louvain-la-Neuve, BE
Louvain-la-Neuve, Belgium
Forward Citations = 23

21 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Albemarle Europe Sprl. Retrieved from https://idiyas.com/company/albemarle-europe-sprl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…